Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl] thieno [3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea

EU orphan designation number: EU/3/12/1001   
Active ingredient: 1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl] thieno [3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea
Indication: Treatment of ovarian cancer
Sponsor: AbbVie Ltd
Maidenhead, SL6 4XE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/06/2012 Centralised Orphan - Designation EMA/OD/002/12 (2012)3845 of 06/06/2012
01/02/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/002/12/T/01 (2013)601 of 30/01/2013